Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

beta-Amyloid neurotoxicity

G Forloni1

  • 1Neurobiology of Alzheimer Unit, Mario Negri, Institute of Pharmacological Research, Milan, Italy.

Functional Neurology
|May 1, 1993
PubMed
Summary
This summary is machine-generated.

Alzheimer's disease involves beta-amyloid deposition in the brain, potentially causing neuronal damage. Further in vivo research is needed to confirm the direct neurotoxic role of beta-amyloid in Alzheimer's disease pathogenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering a multilayered thin-film agarose-based hydrogel to support adipose-derived stromal vascular fraction therapy in spinal cord injury.

International journal of biological macromolecules·2026
Same author

Peripheral inflammation exacerbates α-synuclein toxicity and neuropathology in Parkinson's models.

Neuropathology and applied neurobiology·2020
Same author

Stem cell paracrine effect and delivery strategies for spinal cord injury regeneration.

Journal of controlled release : official journal of the Controlled Release Society·2019
Same author

Review: PrP 106-126 - 25 years after.

Neuropathology and applied neurobiology·2019
Same author

Mesenchymal stem cells encapsulated into biomimetic hydrogel scaffold gradually release CCL2 chemokine in situ preserving cytoarchitecture and promoting functional recovery in spinal cord injury.

Journal of controlled release : official journal of the Controlled Release Society·2018
Same author

Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'.

Journal of internal medicine·2016
Same journal

The need for broader admission criteria for high specialty neurorehabilitation wards in the Italian Health System: not only post-comatose patients.

Functional neurology·2020
Same journal

The origins of the fight against rabies: a journey between the history of neuroscience and university museum collections.

Functional neurology·2020
Same journal

Are paediatric headaches in the emergency department increasing? An Italian experience.

Functional neurology·2020
Same journal

Neurophysiological changes after cognitive-motor tasks in Parkinson's disease patients with deep brain stimulation.

Functional neurology·2020
Same journal

Acute ischemic stroke management in Lebanon: obstacles and solutions.

Functional neurology·2020
Same journal

Does a single bout of exercise impacts BDNF, oxidative stress and epigenetic markers in spinal cord injury patients?

Functional neurology·2020
See all related articles

Area of Science:

  • Neuroscience
  • Neuropathology
  • Molecular Biology

Background:

  • Beta-amyloid (beta A) deposition in brain parenchyma and vessel walls is a key pathological hallmark of Alzheimer's disease (AD).
  • This deposition is linked to neuronal degeneration and cell death.
  • Beta-amyloid is a peptide fragment of a larger transmembrane glycoprotein.

Purpose of the Study:

  • To investigate the neurotoxic activity of beta-amyloid in Alzheimer's disease.
  • To explore the relationship between beta-amyloid's fibrillogenic capacity and its neurotoxicity.
  • To address the inconclusive findings from previous in vivo studies on beta-amyloid's role in AD.

Main Methods:

  • Review of existing literature on beta-amyloid deposition and neurotoxicity.
  • Analysis of in vitro studies demonstrating beta-amyloid peptide toxicity.

Related Experiment Videos

  • Evaluation of in vivo studies investigating the pathogenetic role of beta-amyloid.

    • Main Results:

    • Beta-amyloid deposition is a significant pathological feature in Alzheimer's disease.
    • In vitro models show synthetic beta-amyloid peptides possess neurotoxic activity, correlated with fibril formation.
    • In vivo studies have yielded inconclusive results regarding beta-amyloid's direct neurotoxic effects.

    Conclusions:

    • Beta-amyloid deposition is strongly associated with Alzheimer's disease pathology.
    • The neurotoxic potential of beta-amyloid observed in vitro requires further in vivo validation.
    • Establishing the definitive pathogenetic role of beta-amyloid in Alzheimer's disease necessitates additional in vivo investigations.